The U.S. P2Y12 inhibitors market involves drug products used for the prevention of cardiovascular diseases by inhibiting P2Y12 receptor and platelet aggregation. P2Y12 inhibitors are primarily indicated for acute coronary syndrome and percutaneous coronary intervention as dual antiplatelet therapy along with aspirin. Some of the commonly prescribed P2Y12 inhibitor drugs include clopidogrel,...